Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.

GSK Announces US Vaccine R&D Center

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Industry awaits the final revision of USP General Chapter  and the impact it will have on the evaluation of sterile product package integrity.

Evaluating Package Integrity

Katriona Scoffin is a science writer with Biopharma Technology Ltd., Winchester, England

Efficient freeze-drying processes result in time and energy savings, reduced failure rates, and improved batch consistency.

Designing Trouble-Free Freeze-Drying Processes

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Quality-by-design tools improve efficiency in scale-up of pharmaceutical processes.

Modernizing Scale-Up

Fernando J. Muzzio, PhD, is a professor and the director of the pharmaceutical engineering program at the Department of Chemical and Biochemical Engineering, Rutgers University, 98 Brett Road, Piscataway, NJ 08854-8058, tel. 732.445.3357.

Engineering Research Center for Structured Organic Particulate Systems (ERC-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

M. Sebastian Escotet-Espinoza is a graduate research assistant at the Chemical and Biochemical Engineering Department at Rutgers, The State University of New Jersey,

Sharmista Chatterjee is acting branch I chief/division 1 of process assessment/Office of Process and Facilities, at the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA.

Thomas O’Connor is chemical engineer, science staff at the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA.

Sau Lee is acting associate director for science at the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA.

Maitraye Sen is a graduate research assistant at the Chemical and Biochemical Engineering Department at Rutgers, The State University of New Jersey.

In-silico design facilitates process optimization and evaluation of process control strategies.

Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk Assessment

NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.

NIH Announces Positive Results for Experimental Ebola Vaccine

James P. Agalloco is the president of Agalloco & Associates, P.O. Box 899, Belle Mead, NJ 08502, tel. 908.874.7558, jagalloco@aol.com. He is also a member of Pharmaceutical Technology’s editorial advisory board.

The Human Microbiome Project has increased our understanding of the relationship between humans and microorganisms. The authors offer a new perspective on how this knowledge should be considered in setting standards for pharmaceutical quality control in microbiology.

The Human Microbiome Project and Pharmaceutical Quality Control Microbiology

A drug-product manufacturing classification system (MCS) for oral solid-dosage forms is proposed by an Academy of Pharmaceutical Sciences working group.

Choosing oral solid-dosage production processes: Could a classification system help?

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

In this article, industry experts discuss critical analyses for demonstrating biosimilarity.